Can Fite Biopharma Ltd banner
C

Can Fite Biopharma Ltd
TASE:CANF

Watchlist Manager
Can Fite Biopharma Ltd
TASE:CANF
Watchlist
Price: 539 ILS -0.19%
Market Cap: ₪22.8m

Profitability Summary

Can Fite Biopharma Ltd's profitability score is 11/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

11/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

11/100
Profitability
Score
11/100
Profitability
Score

Margins

Earnings Waterfall
Can Fite Biopharma Ltd

Margins Comparison
Can Fite Biopharma Ltd Competitors

Country Company Market Cap Operating
Margin
Net
Margin
IL
Can Fite Biopharma Ltd
TASE:CANF
22.8m ILS
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
368.3B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
189.4B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175.3B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.7B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
64.8B AUD
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
36.4B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Can Fite Biopharma Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IL
Can Fite Biopharma Ltd
TASE:CANF
22.8m ILS
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
368.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
189.4B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175.3B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.7B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
64.8B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
36.4B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Can Fite Biopharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett